成都静脉曲张的治疗价格多少-【成都川蜀血管病医院】,成都川蜀血管病医院,成都血管畸形去哪治疗,成都市治疗静脉曲张病医院,成都脉管畸形手术哪家医院好,吉首那里有好的血管瘤医院,成都关于前列腺肥大的治疗方法,成都治疗脉管炎哪种方法好

An AK-47 style rifle legally purchased in Nevada and used to attack people at the Gilroy Garlic Festival in northern California couldn't have been purchased legally in California, state Attorney General Xavier Becerra said Monday.Becerra said it's also illegal to transport the assault-style weapon into the state."That weapon could not be sold in California. That weapon cannot be imported into the state of California," Becerra said in response to a question about the assault-style rifle used in the shooting.Becerra added: "There is a very strong likelihood as we develop the evidence that the perpetrator in this particular case violated California law on top of the crimes of homicide and so forth, the crimes that we have that are meant to prevent individuals from carrying out this type of activity."Santino William Legan, 19, killed three people and injured at least 12 others at festival on Sunday with the rifle he bought July 9 in neighboring Nevada, Gilroy Police Chief Scot Smithee told reporters Monday. Three officers who responded within a minute of the gunfire fatally shot Legan, he said.Legan apparently entered the annual festival, which attracts about 100,000 people every year, by using a tool to cut through a back fence and then 1266
A pinch in the leg, a squeal and a trickle of tears. One baby after another in Malawi is getting the first and only vaccine against malaria, one of history’s deadliest and most stubborn of diseases.The southern African nation is rolling out the shots in an unusual pilot program along with Kenya and Ghana. Unlike established vaccines that offer near-complete protection, this new one is only about 40% effective. But experts say it’s worth a try as progress against malaria stalls: Resistance to treatment is growing and the global drop in cases has leveled off. With the vaccine, the hope is to help small children through the most dangerous period of their lives. Spread by mosquito bites, malaria kills more than 400,000 people every year, two-thirds of them under 5 and most in Africa.Seven-month-old Charity Nangware received a shot on a rainy December day at a health clinic in the town of Migowi. She watched curiously as the needle slid into her thigh, then twisted up her face with a howl.“I’m very excited about this,” said her mother, Esther Gonjani, who herself gets malaria’s aches, chills and fever at least once a year and loses a week of field work when one of her children is ill. “They explained it wasn’t perfect, but I feel secure it will relieve the pain.”There is little escaping malaria -- “malungo” in the local Chichewa language -- especially during the five-month rainy season. Stagnant puddles, where mosquitoes breed, surround the homes of brick and thatch and line the dirt roads through tea plantations or fields of maize and sugar cane. In the village of Tomali, the nearest health clinic is a two-hour bike ride away. The longer it takes to get care, the more dangerous malaria can be. Teams from the clinic offer basic medical care during visits once or twice a month, bringing the malaria shot and other vaccines in portable coolers. Treating malaria takes up a good portion of their time during the rainy season, according to Daisy Chikonde, a local health worker.“If this vaccine works, it will reduce the burden,” she said.Resident Doriga Ephrem proudly said her 5-month-old daughter, Grace, didn’t cry when she got the malaria shot.When she heard about the vaccine, Ephrem said her first thought was “protection is here.” Health workers explained, however, that the vaccine is not meant to replace antimalarial drugs or the insecticide-treated bed net she unfolds every night as the sun sets and mosquitoes rise from the shadows. “We even take our evening meals inside the net to avoid mosquitoes,” she said.It took three decades of research to develop the new vaccine, which works against the most common and deadly of the five parasite species that cause malaria. The parasite’s complex life cycle is a huge challenge. It changes forms in different stages of infection and is far harder to target than germs.“We don’t have any vaccines against parasites in routine use. This is uncharted territory,” said Ashley Birkett, who directs PATH’s Malaria Vaccine Initiative, a nonprofit that helped drugmaker GlaxoSmithKline develop the shot, brand-named Mosquirix. The bite of an infected mosquito sends immature parasites called sporozoites into the bloodstream. If they reach the liver, they’ll mature and multiply before spewing back into the blood to cause malaria’s debilitating symptoms. At that point, treatment requires medicines that kill the parasites.Mosquirix uses a piece of the parasite — a protein found only on sporozoites’ surface — in hopes of blocking the liver stage of infection. When a vaccinated child is bitten, the immune system should recognize the parasite and start making antibodies against it.Scientists also are searching for next-generation alternatives. In the pipeline is an experimental vaccine made of whole malaria parasites dissected from mosquitoes’ salivary glands but weakened so they won’t make people sick. Sanaria Inc. has been testing its vaccine in adults, and is planning a large, late-stage study in Equatorial Guinea’s Bioko Island.And the U.S. National Institutes of Health soon will start initial tests of whether injecting people periodically with lab-made antibodies, rather than depending on the immune system to make them, could offer temporary protection during malaria season. Think of them as “potentially short-term vaccines,” NIH’s Dr. Robert Seder told a recent meeting of the American Society of Tropical Medicine and Hygiene.For now, only babies in parts of Malawi, Kenya and Ghana are eligible for the Mosquirix vaccine. After the vaccine was approved in 2015, the World Health Organization said it first wanted a pilot roll-out to see how well it worked in a few countries — in real-world conditions — before recommending that the vaccine be given more widely across Africa. “Everyone is looking forward to getting it,” said Temwa Mzengeza, who oversees Malawi’s vaccine programs. Those eager for the shots include her husband, whom she had to stop from trying to get them, she said.Mzengeza used to come down with malaria several times a year until she started following her own advice to sleep under a net every night. Unlike many other kinds of infections, people can get malaria repeatedly, building up only a partial immunity.In the pilot program that began last year, 360,000 children in the three countries are meant to be vaccinated annually. The first dose is given at about age 5 months and the final, fourth booster near the child’s second birthday.Experts say it is too early to know how well the vaccine is working. They’re watching for malaria deaths, severe infections and cases of meningitis, something reported during studies but not definitively linked to the vaccine.“To do something completely new for malaria is exciting,” said researcher Don Mathanga, who is leading the evaluation in Malawi. The rainy season has brought new challenges, making some rural roads impassable and complicating efforts to track down children due for a shot. So far in Malawi, the first dose reached about half of the children targeted, about 35,000. That dropped to 26,000 for the second dose and 20,000 for the third. That’s not surprising for a new vaccine, Mzengeza said. “It will pick up with time.”At the health clinic in Migowi in Malawi’s southern highlands, workers see signs of hope. Henry Kadzuwa explains the vaccine to mothers waiting at the clinic. He said there was a drop in malaria cases to 40 in the first five months of the program, compared to 78 in the same period in 2018.Even though he wishes his 3-year-old daughter, Angel, could receive the vaccine, “it’s protecting my community. It also makes my work easier,” Kadzuwa said. The Migowi area has one of the country’s highest rates of malaria, and a worn paper register in the clinic’s laboratory lists scores of cases.At the clinic, Agnes Ngubale said she had malaria several years ago and wants to protect her 6-month-old daughter, Lydia, from the disease.“I want her to be healthy and free,” she said. “I want her to be a doctor.”And she has memorized the time for Lydia’s second dose: “Next month, same date.”___Neergaard reported from Washington.___The Associated Press Health and Science Department receives 7200

A member of the Minneapolis City Council revealed this week that he and several other council members are working on finding out what it would take to disband the Minneapolis Police Department. The announcement from Councilmember Steve Fletcher comes a week after George Floyd died while in police custody in Minneapolis. During an appearance on CNN on Wednesday, he called the city’s police department “ungovernable.”"The department is ungovernable,” Fletcher said. “Chief (Medaria) Arradondo is a leader that we've all had very high hopes in and that I imagined could play a role in envisioning the next version of public safety. But he has clearly not been able to make the culture change happen that we were hoping for and investing in.”What it would take to disband the department is unclear. But what is clear is that the department is already seeing a reduced role in the protection of the city. On Wednesday, the Minneapolis Park Board voted to terminate its relationship with the department, and the Minneapolis Police will no longer be involved in guarding events on park property.Fletcher said in a Twitter post that it’s time to “declare policing as we know it a thing of the past.”“Our city needs a public safety capacity that doesn’t fear our residents,” Fletcher said. “That doesn’t need a gun at a community meeting. That considers itself part of our community. That doesn’t resort quickly to pepper spray when people are understandably angry. That doesn’t murder black men.”Despite tensions among the community, a number of leaders from the black community spoke up to defend Arradondo, according to 1629
A women’s clothing line is trying to help females who are running for office in the United States. M.M.LaFleur is offering to lend clothes to any female candidate this spring, at no cost to them. The company says it’s trying do its part to make things “a tiny bit easier” for women running for office. “This spring, we’re taking things a step further by lending out clothes, for free, to any woman who is running for public office – whether it be for the House of Representatives or your town council,” wrote M.M.LaFleur in a 538
A missing 11-year-old Alabama girl was found dead early Saturday, DeKalb County Sheriff Nick Welden said.Amberly Barnett was last seen on Friday around 6 p.m. in the Mt. Vernon community in northeast Alabama, and searchers found her body at about 6:30 a.m. the next day. The location wasn't disclosed.The sheriff did not release the cause of her death or any other information because of the ongoing investigation."I can tell you we are diligently, diligently pursuing different avenues, and Lord willing, we will have answers in the upcoming days," Weldon, who declined to take questions from reporters, said at a brief press conference.A Mt. Vernon resident told CNN affiliate WAAY31 crime of this kind rarely, if ever, happens in the area, which is about 25 miles northeast of the city of Gadsden, Alabama."It was shocking. You don't hear nothing about that around here," Terry Clanton told WAAY31, describing Mt. Vernon as a close-knit community."I want to say directly from the heart, being in this career, in this job, the way we do it is 100% from the heart," Sheriff Welden said. "And my heart is shattered this day, here in DeKalb County, Alabama." 1169
来源:资阳报